Profund Advisors LLC Cara Therapeutics, Inc. Transaction History
Profund Advisors LLC
- $2.67 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding CARA
# of Institutions
10Shares Held
826KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY745KShares$11.9 Million0.0% of portfolio
-
American Portfolios Advisors Holbrook, NY40.4KShares$645,1830.02% of portfolio
-
Rathbones Group PLC Liverpool, X020.2KShares$321,8170.0% of portfolio
-
Rothschild Investment Corp10.6KShares$169,1760.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ8.83KShares$140,9740.0% of portfolio
About Cara Therapeutics, Inc.
- Ticker CARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,725,900
- Market Cap $857M
- Description
- Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...